PCK1 and neoplasm: suggested that inhibiting O-GlcNAcylation of phosphoenolpyruvate carboxykinase 1 (PCK1) at threonine 255 reduces colon cancer cell proliferation, decreased glycolysis, incerased tricarboxylic acid cycle activity, and inhibitd tumor growth in xenograft models.